The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Amyotrophic lateral sclerosis
Open accessAbstract
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and eventual paralysis. Until recently, ALS was classified primarily within the neuromuscular domain, although new imaging and neuropathological data have indicated the involvement of the non-motor neuraxis in disease pathology. In most patients, the mechanisms underlying the development of ALS are poorly understood, although a subset of patients have familial disease and harbour mutations in genes that have various roles in neuronal function. Two possible disease-modifying therapies that can slow disease progression are available for ALS, but patient management is largely mediated by symptomatic therapies, such as the use of muscle relaxants for spasticity and speech therapy for dysarthria. Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which leads to progressive muscle weakness and paralysis. This Primer by Hardiman and colleagues provides a detailed overview of the epidemiology, pathophysiology and diagnosis of ALS, and discusses the management of both the motor and non-motor symptoms of this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2.”
BackgroundA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationSPIKES—A Six-Step Protocol for Delivering Bad News: Application to the Patient with Cancer
Baile, W. F., Buckman, R., Lenzi, R., Glober, G., Beale, E. A., & Kudelka, A. P. (2000) · The Oncologist · doi:10.1634/theoncologist.5-4-302 · Cited by 3,075
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Self-citationKiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Self-citationMutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,564
Self-citationMutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., Diaz, Z., MacLea, K. S., Freibaum, B., Li, S., Molliex, A., et al. (2013) · Nature · doi:10.1038/nature11922 · Cited by 1,475
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,325
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Johnson, J. O., Mandrioli, J., Benatar, M., Abramzon, Y., Van Deerlin, V. M., Trojanowski, J. Q., Gibbs, J. R., Brunetti, M., Gronka, S., Wuu, J., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.036 · Cited by 1,235
Self-citationMutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Deng, H.-X., Chen, W., Hong, S.-T., Boycott, K. M., Gorrie, G. H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H., et al. (2011) · Nature · doi:10.1038/nature10353 · Cited by 1,174
Bourke, S. C., Tomlinson, M., Williams, T. L., Bullock, R. E., Shaw, P. J., & Gibson, G. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70326-4 · Cited by 1,171
Self-citationThe EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Self-citationThe C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978
Self-citationMutant dynactin in motor neuron disease
Puls, I., Jonnakuty, C., LaMonte, B. H., Holzbaur, E. L. F., Tokito, M., Mann, E., Floeter, M. K., Bidus, K., Drayna, D., Oh, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1123 · Cited by 960
Abe, K., Aoki, M., Tsuji, S., Itoyama, Y., Sobue, G., Togo, M., Hamada, C., Tanaka, M., Akimoto, M., Nakamura, K., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30115-1 · Cited by 935
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922
Strong, M. J., Abrahams, S., Goldstein, L. H., Woolley, S., Mclaughlin, P., Snowden, J., Mioshi, E., Roberts-South, A., Benatar, M., HortobáGyi, T., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1267768 · Cited by 909
Nishimura, A. L., Mitne-Neto, M., Silva, H. C. A., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J. R. M., Gillingwater, T., Webb, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425287 · Cited by 880
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Chiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862
Self-citationConicella, A. E., Zerze, G. H., Mittal, J., & Fawzi, N. L. (2016) · Structure · doi:10.1016/j.str.2016.07.007 · Cited by 857
Is quality of life determined by expectations or experience?
Carr, A. J., Gibson, B., & Robinson, P. G. (2001) · BMJ · doi:10.1136/bmj.322.7296.1240 · Cited by 842
GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841
Schwartz, C. E., & Sprangers, M. A. G. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00047-7 · Cited by 828
Skourti-Stathaki, K., Proudfoot, N. J., & Gromak, N. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.026 · Cited by 819
DNA/RNA Helicase Gene Mutations in a Form of Juvenile Amyotrophic Lateral Sclerosis (ALS4)
Chen, Y.-Z., Bennett, C. L., Huynh, H. M., Blair, I. P., Puls, I., Irobi, J., Dierick, I., Abel, A., Kennerson, M. L., Rabin, B. A., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/421054 · Cited by 808
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0141 · Cited by 807
Role of Stress Granules and RNA-Binding Proteins in Neurodegeneration: A Mini-Review
Vanderweyde, T., Youmans, K., Liu-Yesucevitz, L., & Wolozin, B. (2013) · Gerontology · doi:10.1159/000354170 · Cited by 805
p62/SQSTM 1 functions as a signaling hub and an autophagy adaptor
Katsuragi, Y., Ichimura, Y., & Komatsu, M. (2015) · The FEBS Journal · doi:10.1111/febs.13540 · Cited by 788
R loops: new modulators of genome dynamics and function
Santos-Pereira, J. M., & Aguilera, A. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3961 · Cited by 775
Incidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772
Self-citationYang, Y., Hentati, A., Deng, H.-X., Dabbagh, O., Sasaki, T., Hirano, M., Hung, W.-Y., Ouahchi, K., Yan, J., Azim, A. C., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-160 · Cited by 743
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
Hadano, S., Hand, C. K., Osuga, H., Yanagisawa, Y., Otomo, A., Devon, R. S., Miyamoto, N., Showguchi-Miyata, J., Okada, Y., Singaraja, R., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-166 · Cited by 678
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Self-citationThe syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study
Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., Lynch, C., Pender, N., & Hardiman, O. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300188 · Cited by 667
Self-citationWinton, M. J., Igaz, L. M., Wong, M. M., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800342200 · Cited by 659
<emph type="ital">SQSTM1</emph> Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Fecto, F. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.250 · Cited by 650
Stoica, R., De Vos, K. J., Paillusson, S., Mueller, S., Sancho, R. M., Lau, K.-F., Vizcay-Barrena, G., Lin, W.-L., Xu, Y.-F., Lewis, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4996 · Cited by 618
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615
Self-citationWhat is the role of protein aggregation in neurodegeneration?
Ross, C. A., & Poirier, M. A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1742 · Cited by 604
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis
Wu, C.-H., Fallini, C., Ticozzi, N., Keagle, P. J., Sapp, P. C., Piotrowska, K., Lowe, P., Koppers, M., McKenna-Yasek, D., Baron, D. M., et al. (2012) · Nature · doi:10.1038/nature11280 · Cited by 603
Self-citationKang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599
Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 572
PARALS Registry, van Rheenen, W., SLALOM Group, SLAP Registry, FALS Sequencing Consortium, SLAGEN Consortium, NNIPPS Study Group, Shatunov, A., Dekker, A. M., McLaughlin, R. L., et al. (2016) · Nature Genetics · doi:10.1038/ng.3622 · Cited by 571
Self-citationScreening for cognition and behaviour changes in ALS
Abrahams, S., Newton, J., Niven, E., Foley, J., & Bak, T. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.805784 · Cited by 570
VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis
De Vos, K. J., Mórotz, G. M., Stoica, R., Tudor, E. L., Lau, K.-F., Ackerley, S., Warley, A., Shaw, C. E., & Miller, C. C. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr559 · Cited by 569
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 537
Cooper-Knock, J., Bury, J. J., Heath, P. R., Wyles, M., Higginbottom, A., Gelsthorpe, C., Highley, J. R., Hautbergue, G., Rattray, M., Kirby, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127376 · Cited by 513
Self-citationPhase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics
Boeynaems, S., Bogaert, E., Kovacs, D., Konijnenberg, A., Timmerman, E., Volkov, A., Guharoy, M., De Decker, M., Jaspers, T., Ryan, V. H., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.013 · Cited by 501
Self-citationLee, Y.-B., Chen, H.-J., Peres, J. N., Gomez-Deza, J., Attig, J., Štalekar, M., Troakes, C., Nishimura, A. L., Scotter, E. L., Vance, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.049 · Cited by 496
Tsang, C. K., Liu, Y., Thomas, J., Zhang, Y., & Zheng, X. F. S. (2014) · Nature Communications · doi:10.1038/ncomms4446 · Cited by 496
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
Traynor, B. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1258 · Cited by 493
Arnold, E. S., Ling, S.-C., Huelga, S. C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H. B., McAlonis-Downes, M., Platoshyn, O., Parone, P. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222809110 · Cited by 492
Bannwarth, S., Ait-El-Mkadem, S., Chaussenot, A., Genin, E. C., Lacas-Gervais, S., Fragaki, K., Berg-Alonso, L., Kageyama, Y., Serre, V., Moore, D. G., et al. (2014) · Brain · doi:10.1093/brain/awu138 · Cited by 488
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Gaiottino, J., Norgren, N., Dobson, R., Topping, J., Nissim, A., Malaspina, A., Bestwick, J. P., Monsch, A. U., Regeniter, A., Lindberg, R. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075091 · Cited by 486
A revision of the El Escorial criteria - 2015
Ludolph, A., Drory, V., Hardiman, O., Nakano, I., Ravits, J., Robberecht, W., Shefner, J., & for The WFN Research Group On ALS/MND (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1049183 · Cited by 475
Self-citationProjected increase in amyotrophic lateral sclerosis from 2015 to 2040
Arthur, K. C., Calvo, A., Price, T. R., Geiger, J. T., Chiò, A., & Traynor, B. J. (2016) · Nature Communications · doi:10.1038/ncomms12408 · Cited by 474
The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids
Aguzzi, A., & Rajendran, L. (2009) · Neuron · doi:10.1016/j.neuron.2009.12.016 · Cited by 473
TAR DNA-binding protein 43 in neurodegenerative disease
Chen-Plotkin, A. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.18 · Cited by 468
The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity
Wang, W., Wang, L., Lu, J., Siedlak, S. L., Fujioka, H., Liang, J., Jiang, S., Ma, X., Jiang, Z., da Rocha, E. L., et al. (2016) · Nature Medicine · doi:10.1038/nm.4130 · Cited by 459
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis
ITALSGEN, Johnson, J. O., Pioro, E. P., Boehringer, A., Chia, R., Feit, H., Renton, A. E., Pliner, H. A., Abramzon, Y., Marangi, G., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3688 · Cited by 445
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS
Liao, B., Zhao, W., Beers, D. R., Henkel, J. S., & Appel, S. H. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.011 · Cited by 438
Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons
Wang, W.-Y., Pan, L., Su, S. C., Quinn, E. J., Sasaki, M., Jimenez, J. C., Mackenzie, I. R. A., Huang, E. J., & Tsai, L.-H. (2013) · Nature Neuroscience · doi:10.1038/nn.3514 · Cited by 438
An early step in wobble uridine tRNA modification requires the Elongator complex
HUANG, B., JOHANSSON, M. J. O., & BYSTRÖM, A. S. (2005) · RNA · doi:10.1261/rna.7247705 · Cited by 434
A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis
Al‐Saif, A., Al‐Mohanna, F., & Bohlega, S. (2011) · Annals of Neurology · doi:10.1002/ana.22534 · Cited by 430
Lopez-Gonzalez, R., Lu, Y., Gendron, T. F., Karydas, A., Tran, H., Yang, D., Petrucelli, L., Miller, B. L., Almeida, S., & Gao, F.-B. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.015 · Cited by 419
Deficits in axonal transport precede ALS symptoms in vivo
Bilsland, L. G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., & Schiavo, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006869107 · Cited by 418
Deleterious Variants of FIG4, a Phosphoinositide Phosphatase, in Patients with ALS
Chow, C. Y., Landers, J. E., Bergren, S. K., Sapp, P. C., Grant, A. E., Jones, J. M., Everett, L., Lenk, G. M., McKenna-Yasek, D. M., Weisman, L. S., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.010 · Cited by 407
The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
Webster, C. P., Smith, E. F., Bauer, C. S., Moller, A., Hautbergue, G. M., Ferraiuolo, L., Myszczynska, M. A., Higginbottom, A., Walsh, M. J., Whitworth, A. J., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694401 · Cited by 404
Self-citationALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. M., Morrison, K. E., Pall, H. S., Hardiman, O., Collinge, J., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000231510.89311.8b · Cited by 395
Self-citationAmyotrophic lateral sclerosis: moving towards a new classification system
Al-Chalabi, A., Hardiman, O., Kiernan, M. C., Chiò, A., Rix-Brooks, B., & van den Berg, L. H. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30199-5 · Cited by 390
Self-citationRegulation of Oligodendrocyte Development and Myelination by Glucose and Lactate
Rinholm, J. E., Hamilton, N. B., Kessaris, N., Richardson, W. D., Bergersen, L. H., & Attwell, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3516-10.2011 · Cited by 383
Physiological functions and pathobiology of TDP‐43 and FUS/TLS proteins
Ratti, A., & Buratti, E. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13625 · Cited by 383
Siddique, T., Figlewigz, D. A., Pericak-Vance, M. A., Haines, J. L., Rouleau, G., Jeffers, A. J., Sapp, P., Hung, W.-Y., Bebout, J., McKenna-Yasek, D., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242001 · Cited by 382
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
Polymenidou, M., & Cleveland, D. W. (2011) · Cell · doi:10.1016/j.cell.2011.10.011 · Cited by 376
Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect
Pioro, E. P., Brooks, B. R., Cummings, J., Schiffer, R., Thisted, R. A., Wynn, D., Hepner, A., & Kaye, R. (2010) · Annals of Neurology · doi:10.1002/ana.22093 · Cited by 370
Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS
Smith, B. N., Ticozzi, N., Fallini, C., Gkazi, A. S., Topp, S., Kenna, K. P., Scotter, E. L., Kost, J., Keagle, P., Miller, J. W., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.027 · Cited by 367
Self-citationMultidisciplinary ALS care improves quality of life in patients with ALS
Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J. H. J., & Van den Berg, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000180717.29273.12 · Cited by 343
Self-citationEvidence for an oligogenic basis of amyotrophic lateral sclerosis
van Blitterswijk, M., van Es, M. A., Hennekam, E. A. M., Dooijes, D., van Rheenen, W., Medic, J., Bourque, P. R., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds199 · Cited by 341
Self-citationMagrané, J., Cortez, C., Gan, W.-B., & Manfredi, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt528 · Cited by 333
Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions
Cooper-Knock, J., Walsh, M. J., Higginbottom, A., Robin Highley, J., Dickman, M. J., Edbauer, D., Ince, P. G., Wharton, S. B., Wilson, S. A., Kirby, J., et al. (2014) · Brain · doi:10.1093/brain/awu120 · Cited by 319
Self-citationMatsumoto, G., Shimogori, T., Hattori, N., & Nukina, N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv179 · Cited by 317
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Steinacker, P., Feneberg, E., Weishaupt, J., Brettschneider, J., Tumani, H., Andersen, P. M., von Arnim, C. A. F., Böhm, S., Kassubek, J., Kubisch, C., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311387 · Cited by 317
Reddy, K., Zamiri, B., Stanley, S. Y. R., Macgregor, R. B., & Pearson, C. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.452532 · Cited by 313
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome
Hjerpe, R., Bett, J. S., Keuss, M. J., Solovyova, A., McWilliams, T. G., Johnson, C., Sahu, I., Varghese, J., Wood, N., Wightman, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.001 · Cited by 309
Noninvasive ventilation in ALS: Indications and effect on quality of life
Bourke, S. C., Bullock, R. E., Williams, T. L., Shaw, P. J., & Gibson, G. J. (2003) · Neurology · doi:10.1212/01.wnl.0000076182.13137.38 · Cited by 301
Self-citationVariants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration
Simpson, C. L., Lemmens, R., Miskiewicz, K., Broom, W. J., Hansen, V. K., van Vught, P. W. J., Landers, J. E., Sapp, P., Van Den Bosch, L., Knight, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn375 · Cited by 291
Self-citationEvaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis
Couthouis, J., Hart, M. P., Erion, R., King, O. D., Diaz, Z., Nakaya, T., Ibrahim, F., Kim, H.-J., Mojsilovic-Petrovic, J., Panossian, S., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds116 · Cited by 289
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
SLAGEN Consortium, Kenna, K. P., van Doormaal, P. T. C., Dekker, A. M., Ticozzi, N., Kenna, B. J., Diekstra, F. P., van Rheenen, W., van Eijk, K. R., Jones, A. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3626 · Cited by 287
Self-citationGene discovery in amyotrophic lateral sclerosis: implications for clinical management
Al-Chalabi, A., van den Berg, L. H., & Veldink, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.182 · Cited by 287
Self-citationQuality of life in ALS depends on factors other than strength and physical function
Simmons, Z., Bremer, B. A., Robbins, R. A., Walsh, S. M., & Fischer, S. (2000) · Neurology · doi:10.1212/wnl.55.3.388 · Cited by 279
Self-citationCognitive changes predict functional decline in ALS: A population-based longitudinal study
Elamin, M., Bede, P., Byrne, S., Jordan, N., Gallagher, L., Wynne, B., O’Brien, C., Phukan, J., Lynch, C., Pender, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18ac · Cited by 272
Self-citationUrushitani, M., Kurisu, J., Tsukita, K., & Takahashi, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01211.x · Cited by 268
Higgins, C. M., Jung, C., & Xu, Z. (2003) · BMC Neuroscience · doi:10.1186/1471-2202-4-16 · Cited by 262
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
Philips, T., Bento-Abreu, A., Nonneman, A., Haeck, W., Staats, K., Geelen, V., Hersmus, N., Küsters, B., Van Den Bosch, L., Van Damme, P., et al. (2013) · Brain · doi:10.1093/brain/aws339 · Cited by 260
Self-citationStoica, R., Paillusson, S., Gomez‐Suaga, P., Mitchell, J. C., Lau, D. H., Gray, E. H., Sancho, R. M., Vizcay‐Barrena, G., De Vos, K. J., Shaw, C. E., et al. (2016) · EMBO reports · doi:10.15252/embr.201541726 · Cited by 252
Use of Sniff Nasal-Inspiratory Force to Predict Survival in Amyotrophic Lateral Sclerosis
Morgan, R. K., McNally, S., Alexander, M., Conroy, R., Hardiman, O., & Costello, R. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-314oc · Cited by 250
Self-citationMolecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis
Corcia, P., Tauber, C., Vercoullie, J., Arlicot, N., Prunier, C., Praline, J., Nicolas, G., Venel, Y., Hommet, C., Baulieu, J.-L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052941 · Cited by 249
Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis
Hegedus, J., Putman, C. T., Tyreman, N., & Gordon, T. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149286 · Cited by 248
Amyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.109 · Cited by 242
Self-citationA prospective study of quality of life in ALS patients treated with noninvasive ventilation
Lyall, R. A., Donaldson, N., Fleming, T., Wood, C., Newsom–Davis, I., Polkey, M. I., Leigh, P. N., & Moxham, J. (2001) · Neurology · doi:10.1212/wnl.57.1.153 · Cited by 238
Wang, M.-D., Little, J., Gomes, J., Cashman, N. R., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.015 · Cited by 233
The course of the terminal phase in patients with amyotrophic lateral sclerosis
Neudert, C., Oliver, D., Wasner, M., & Borasio, G. D. (2001) · Journal of Neurology · doi:10.1007/s004150170140 · Cited by 233
Chio, A. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083402 · Cited by 232
Self-citationRooney, J., Byrne, S., Heverin, M., Tobin, K., Dick, A., Donaghy, C., & Hardiman, O. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309601 · Cited by 225
Self-citationActive zone scaffolds differentially accumulate Unc13 isoforms to tune Ca2+ channel–vesicle coupling
Böhme, M. A., Beis, C., Reddy-Alla, S., Reynolds, E., Mampell, M. M., Grasskamp, A. T., Lützkendorf, J., Bergeron, D. D., Driller, J. H., Babikir, H., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4364 · Cited by 219
Wang, S.-J., Wang, K.-Y., & Wang, W.-C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.019 · Cited by 210
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
Chiò, A., Hammond, E. R., Mora, G., Bonito, V., & Filippini, G. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306589 · Cited by 206
Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33–q35
Hentati, A., Bejaoui, K., Pericak-Vance, M. A., Hentati, F., Speer, M. C., Hung, W.-Y., Figlewicz, D. A., Haines, J., Rimmler, J., Ben Hamida, C., et al. (1994) · Nature Genetics · doi:10.1038/ng0794-425 · Cited by 205
The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease
Haeusler, A. R., Donnelly, C. J., & Rothstein, J. D. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.38 · Cited by 205
A Frameshift Deletion in Peripherin Gene Associated with Amyotrophic Lateral Sclerosis
Gros-Louis, F., Larivière, R., Gowing, G., Laurent, S., Camu, W., Bouchard, J.-P., Meininger, V., Rouleau, G. A., & Julien, J.-P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408139200 · Cited by 204
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 203
Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2
Ferguson, C. J., Lenk, G. M., & Meisler, M. H. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp460 · Cited by 202
Genin, E. C., Plutino, M., Bannwarth, S., Villa, E., Cisneros‐Barroso, E., Roy, M., Ortega‐Vila, B., Fragaki, K., Lespinasse, F., Pinero‐Martos, E., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505496 · Cited by 199
Luty, A. A., Kwok, J. B. J., Dobson‐Stone, C., Loy, C. T., Coupland, K. G., Karlström, H., Sobow, T., Tchorzewska, J., Maruszak, A., Barcikowska, M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22274 · Cited by 196
Gaiani, A., Martinelli, I., Bello, L., Querin, G., Puthenparampil, M., Ruggero, S., Toffanin, E., Cagnin, A., Briani, C., Pegoraro, E., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5398 · Cited by 196
Chiò, A., Calvo, A., Bovio, G., Canosa, A., Bertuzzo, D., Galmozzi, F., Cugnasco, P., Clerico, M., De Mercanti, S., Bersano, E., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1129 · Cited by 195
Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice
Wang, L., Gutmann, D. H., & Roos, R. P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq463 · Cited by 193
Laird, F. M., Farah, M. H., Ackerley, S., Hoke, A., Maragakis, N., Rothstein, J. D., Griffin, J., Price, D. L., Martin, L. J., & Wong, P. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4231-07.2008 · Cited by 189
Chen, H.-J., Anagnostou, G., Chai, A., Withers, J., Morris, A., Adhikaree, J., Pennetta, G., & de Belleroche, J. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161398 · Cited by 189
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism
Ferraiuolo, L., Meyer, K., Sherwood, T. W., Vick, J., Likhite, S., Frakes, A., Miranda, C. J., Braun, L., Heath, P. R., Pineda, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607496113 · Cited by 189
Self-citationC9orf72 expansion disrupts ATM-mediated chromosomal break repair
Walker, C., Herranz-Martin, S., Karyka, E., Liao, C., Lewis, K., Elsayed, W., Lukashchuk, V., Chiang, S.-C., Ray, S., Mulcahy, P. J., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4604 · Cited by 185
Self-citationAlsin Is a Rab5 and Rac1 Guanine Nucleotide Exchange Factor
Topp, J. D., Gray, N. W., Gerard, R. D., & Horazdovsky, B. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313504200 · Cited by 184
Parone, P. A., Da Cruz, S., Han, J. S., McAlonis-Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 177
Velde, C. V., McDonald, K. K., Boukhedimi, Y., McAlonis‐Downes, M., Lobsiger, C. S., Hadj, S. B., Zandona, A., Julien, J., Shah, S. B., & Cleveland, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022031 · Cited by 171
A Novel Locus for Familial Amyotrophic Lateral Sclerosis, on Chromosome 18q
Hand, C. K., Khoris, J., Salachas, F., Gros‐Louis, F., Lopes, A. A. S., Mayeux‐Portas, V., Brown, R. H., Meininger, V., Camu, W., & Rouleau, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/337945 · Cited by 169
Kapeli, K., Pratt, G. A., Vu, A. Q., Hutt, K. R., Martinez, F. J., Sundararaman, B., Batra, R., Freese, P., Lambert, N. J., Huelga, S. C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12143 · Cited by 166
Devon, R. S., Orban, P. C., Gerrow, K., Barbieri, M. A., Schwab, C., Cao, L. P., Helm, J., Bissada, N., Cruz-Aguado, R., Davidson, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510197103 · Cited by 165
Kori, M., Aydın, B., Ünal, S., Arğa, K. Y., & Kazan, D. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0106 · Cited by 165
Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study
(2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00104-0 · Cited by 164
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.
Saxena, S. K., Rybak, S. M., Davey, R. T., Youle, R. J., & Ackerman, E. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36710-9 · Cited by 163
Takahashi, Y., Fukuda, Y., Yoshimura, J., Toyoda, A., Kurppa, K. J., Moritoyo, H., Belzil, V., Dion, P. A., Higasa, K., Doi, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.008 · Cited by 162
TBK1 Mediates Crosstalk Between the Innate Immune Response and Autophagy
Weidberg, H., & Elazar, Z. (2011) · Science Signaling · doi:10.1126/scisignal.2002355 · Cited by 159
Proposed criteria for familial amyotrophic lateral sclerosis
Byrne, S., Bede, P., Elamin, M., Kenna, K. P., Lynch, C. M., McLaughlin, R. L., & Hardiman, O. M. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.545420 · Cited by 154
Self-citationEndogenous TDP-43 localized to stress granules can subsequently form protein aggregates
Parker, S. J., Meyerowitz, J., James, J. L., Liddell, J. R., Crouch, P. J., Kanninen, K. M., & White, A. R. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.019 · Cited by 153
Goode, A., Butler, K., Long, J., Cavey, J., Scott, D., Shaw, B., Sollenberger, J., Gell, C., Johansen, T., Oldham, N. J., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1170257 · Cited by 153
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale
Balendra, R., Jones, A., Jivraj, N. K., Knights, C., Ellis, C. M., Burman, R., Turner, M. R., Leigh, P. N., Shaw, C. E., & Al‐Chalabi, A. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.897357 · Cited by 151
Self-citationTartaglia, M. C., Rowe, A., Findlater, K., Orange, J. B., Grace, G., & Strong, M. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.232 · Cited by 151
Hautbergue, G. M., Castelli, L. M., Ferraiuolo, L., Sánchez-Martínez, Á., Cooper‐Knock, J., Higginbottom, A., Lin, Y.-H., Bauer, C. S., Dodd, J. E., Myszczynska, M. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms16063 · Cited by 143
Self-citationRandomized double‐blind study of botulinum toxin type B for sialorrhea in als patients
Jackson, C. E., Gronseth, G., Rosenfeld, J., Barohn, R. J., Dubinsky, R., Simpson, C. B., McVey, A., Kittrell, P., King, R. M., & Herbelin, L. L. (2009) · Muscle & Nerve · doi:10.1002/mus.21213 · Cited by 142
Marin, B., Logroscino, G., Boumédiène, F., Labrunie, A., Couratier, P., Babron, M., Leutenegger, A., Preux, P., & Beghi, E. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0090-x · Cited by 137
Self-citationReduced frequency of ALS in an ethnically mixed population
Zaldívar, T., Gutiérrez, J., Lara, G., Carbonara, M., Logroscino, G., & Hardiman, O. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a55f7b · Cited by 136
Self-citationGuidubaldi, A., Fasano, A. A., Ialongo, T., et al. (2011) · Movement Disorders · doi:10.1002/mds.23473 · Cited by 135
Functions of FUS/TLS From DNA Repair to Stress Response: Implications for ALS
Sama, R. R. K., Ward, C. L., & Bosco, D. A. (2014) · ASN NEURO · doi:10.1177/1759091414544472 · Cited by 135
Pain in amyotrophic lateral sclerosis
Chiò, A., Mora, G., & Lauria, G. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30358-1 · Cited by 134
Self-citationSporadic lower motor neuron disease with adult onset: classification of subtypes
van den Berg‐Vos, R. M., Visser, J., Franssen, H., de Visser, M., de Jong, J. M. B. V., Kalmijn, S., Wokke, J. H. J., & van den Berg, L. H. (2003) · Brain · doi:10.1093/brain/awg117 · Cited by 134
Genetic counselling in ALS: facts, uncertainties and clinical suggestions
Chiò, A., Battistini, S., Calvo, A., Caponnetto, C., Conforti, F. L., Corbo, M., Giannini, F., Mandrioli, J., Mora, G., Sabatelli, M., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305546 · Cited by 133
Self-citationBeghi, E., Chiò, A., Couratier, P., Esteban‐Pérez, J., Hardiman, O. M., Logroscino, G., Millul, A., Mitchell, D. J., Preux, P., Pupillo, E., et al. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.502940 · Cited by 132
Self-citationIdentification of Two Novel Loci for Dominantly Inherited Familial Amyotrophic Lateral Sclerosis
Sapp, P. C., Hosler, B. A., McKenna-Yasek, D. M., Chin, W., Gann, A., Genise, H., Gorenstein, J., Huang, M. C., Sailer, W., Scheffler, M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/377158 · Cited by 132
Pathologic laughter and crying in ALS: a search for their origin
Gallagher, J. P. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03851.x · Cited by 132
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
Elamin, M., Bede, P., Montuschi, A., Pender, N. P., Chiò, A., & Hardiman, O. M. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7731-6 · Cited by 128
Self-citationThe changing picture of amyotrophic lateral sclerosis: lessons from European registers
Hardiman, O., Al-Chalabi, A., Brayne, C., Beghi, E., van den Berg, L. H., Chio, A., Martin, S., Logroscino, G., & Rooney, J. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314495 · Cited by 126
Self-citationLessons of ALS imaging: Pitfalls and future directions — A critical review
Bede, P., & Hardiman, O. M. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.02.011 · Cited by 126
Self-citationThe diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis
Turner, M. R., Scaber, J., Goodfellow, J. A., Lord, M. E., Marsden, R., & Talbot, K. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.028 · Cited by 123
The ALS/PDC syndrome of Guam and the cycad hypothesis
Steele, J. C., & McGeer, P. L. (2008) · Neurology · doi:10.1212/01.wnl.0000312571.81091.26 · Cited by 121
The El Escorial criteria: Strengths and weaknesses
Agosta, F., Al‐Chalabi, A., Filippi, M., Hardiman, O. M., Kaji, R., Meininger, V., Nakano, I., Shaw, P. J., Shefner, J. M., van den Berg, L. H., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.964258 · Cited by 116
Self-citationHeiman-Patterson, T. D., Sher, R. B., Blankenhorn, E. A., Alexander, G. M., Deitch, J. S., Kunst, C. B., Maragakis, N. J., & Cox, G. A. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.550626 · Cited by 116
Körner, S., Hendricks, M., Kollewe, K., Zapf, A., Dengler, R., Silani, V., & Petri, S. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-84 · Cited by 112
Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors
Burke, T., Elamin, M., Galvin, M., Hardiman, O. M., & Pender, N. P. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7746-z · Cited by 111
Self-citationBasso, M., Samengo, G., Nardo, G., Massignan, T., D’Alessandro, G., Tartari, S., Cantoni, L., Marino, M., Cheroni, C., Biasi, S. D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008130 · Cited by 111
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Smith, R. A., Pioro, E. P., Myers, K. J., Sirdofsky, M., Goslin, K., Meekins, G. D., Yu, H., Wymer, J. P., Cudkowicz, M., Macklin, E. A., et al. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0508-5 · Cited by 111
Hadano, S., Otomo, A., Kunita, R., Suzuki-Utsunomiya, K., Akatsuka, A., Koike, M., Aoki, M., Uchiyama, Y., Itoyama, Y., & Ikeda, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009805 · Cited by 110
Riluzole, a glutamate release inhibitor, and motor behavior
Kretschmer, B. D., Kratzer, U., & Schmidt, W. (1998) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005241 · Cited by 107
A randomized trial of mexiletine in ALS
Weiss, M. D., Macklin, E. A., Simmons, Z., Knox, A., Greenblatt, D. J., Atassi, N., Graves, M. C., Parziale, N., Salameh, J. S., Quinn, C. C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002507 · Cited by 107
Self-citationDisease Course and Prognostic Factors of Progressive Muscular Atrophy
Visser, J., van den Berg‐Vos, R. M., Franssen, H., van den Berg, L. H., Wokke, J. H. J., de Jong, J. M. B. V., Holman, R., de Haan, R. J., & de Visser, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.522 · Cited by 105
Dorst, J., Dupuis, L., Petri, S., Kollewe, K., Abdulla, S., Wolf, J., Weber, M., Czell, D., Burkhardt, C., Hanisch, F., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7646-2 · Cited by 104
Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?
Lee, S., & Kim, H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.1.1 · Cited by 104
18 F-FDG-PET correlates of cognitive impairment in ALS
Canosa, A., Pagani, M., Cistaro, A., Montuschi, A., Iazzolino, B., Fania, P., Cammarosano, S., Ilardi, A., Moglia, C., Calvo, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002242 · Cited by 103
Fujimura, C., Kimura, F., Ishida, S., Nakajima, H., Hosokawa, T., Sugino, M., & Hanafusa, T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300141 · Cited by 102
TDP‐43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons
Schwenk, B. M., Hartmann, H., Serdaroglu, A., Schludi, M. H., Hornburg, D., Meissner, F., Orozco, D., Colombo, A. V., Tahirović, S., Michaelsen, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694221 · Cited by 101
Patient-Perceived Outcomes and Quality of Life in ALS
Simmons, Z. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0322-x · Cited by 98
Self-citationSurvey of cannabis use in patients with amyotrophic lateral sclerosis
Amtmann, D., Weydt, P., Johnson, K. L., Jensen, M. P., & Carter, G. T. (2004) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910402100206 · Cited by 98
Bradley, W. G., Borenstein, A. R., Nelson, L. M., Codd, G. A., Rosen, B. H., Stommel, E. W., & Cox, P. A. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.750364 · Cited by 97
Mechanisms of genome instability induced by RNA-processing defects
Chan, Y. A., Hieter, P., & Stirling, P. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.03.005 · Cited by 96
Breaking the news: A survey of ALS patients and their caregivers
McCluskey, L. F., Casarett, D., & Siderowf, A. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020772 · Cited by 93
Burke, T., Pinto‐Grau, M., Lonergan, K., Bede, P., O’Sullivan, M., Heverin, M., Vajda, A., McLaughlin, R. L., Pender, N. P., & Hardiman, O. M. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.407 · Cited by 91
Self-citationEdaravone: a new treatment for ALS on the horizon?
Hardiman, O. M., & van den Berg, L. H. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30163-1 · Cited by 90
Self-citationSchuster, C., Elamin, M., Hardiman, O. M., & Bede, P. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309888 · Cited by 89
Self-citationLondral, A. R. M., Pinto, A. C., Pinto, S., Azevedo, L., & de Carvalho, M. A. (2015) · Muscle & Nerve · doi:10.1002/mus.24659 · Cited by 89
The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair
Fang, X., Lin, H., Wang, X., Zuo, Q., Qin, J., & Zhang, P. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv076 · Cited by 86
Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study
Chiò, A., Calvo, A., Moglia, C., Gamna, F., Mattei, A., Mazzini, L., Mora, G., & PARALS, A. T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300472 · Cited by 85
Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians
Roggenbuck, J., Quick, A. D., & Kolb, S. J. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.107 · Cited by 84
Pinto‐Grau, M., Burke, T., Lonergan, K., McHugh, C., Mays, I., Madden, C., Vajda, A., Heverin, M., Elamin, M., Hardiman, O. M., et al. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1249887 · Cited by 84
Self-citationComparison of the King’s and MiToS staging systems for ALS
Fang, T., Khleifat, A. A., Stahl, D. R., Torre, C. L. L., Murphy, C., LicalS, U.-M., Young, C. A., Shaw, P. J., Leigh, P. N., & Al‐Chalabi, A. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1265565 · Cited by 83
Self-citationMarin, B., Hamidou, B., Couratier, P., Nicol, M., Delzor, A., Raymondeau, M., Druet‐Cabanac, M., Lautrette, G., Boumédiène, F., Preux, P., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12474 · Cited by 82
Chang, L., & Monteiro, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130162 · Cited by 80
Merrilees, J. J., Klapper, J., Murphy, J. M., Lomen, C. E., & Miller, B. L. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482961003605788 · Cited by 79
Körner, S., Siniawski, M., Kollewe, K., Rath, K. J., Krampfl, K., Zapf, A., Dengler, R., & Petri, S. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/17482968.2012.692382 · Cited by 77
Brain–computer interfaces in amyotrophic lateral sclerosis: A metanalysis
Marchetti, M., & Priftis, K. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.09.017 · Cited by 77
Research works printed but not linked: 6
- Wong, Y. C. & Holzbaur, E. L. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl Acad. Sci. USA 111, E4439–E4448 (2014).
- Pizzo, E. et al. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. J. Cell Sci. 126, 4308–4319 (2013).
- Garcia, M. L. et al. Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis. Neurobiol. Dis. 21, 102–109 (2006). · doi:10.1016/j.nbd.2005.06.016
- Mastaglia, F. L. & Needham, M. Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J. Clin. Neurosci. 22, 6–13 (2015). · doi:10.1016/j.jocn.2014.09.012
- Juntas-Morales, R., Pageot, N., Alphandery, S. & Camu, W. The use of peripherally inserted central catheter in amyotrophic lateral sclerosis patients at a later stage. Eur. Neurol. 77, 87–90 (2017). · doi:10.1159/000454858
- Gladman, M., Dehaan, M., Pinto, H., Geerts, W. & Zinman, L. Venous thromboembolism in amyotrophic lateral sclerosis: a prospective study. Neurology 82, 1674–1677 (2014). · doi:10.1212/wnl.0000000000000405
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085
Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
Kapellos, T. S., Bonaguro, L., Gemünd, I., Reusch, N., Saglam, A., Hinkley, E. R., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02035 · Cited by 890
Epidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Metadata
- Authors
- Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-10-05
- Volume
- 3
- Issue
- 1
- Pages
- 17071-17071
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211041983
- Cited by
- 1,414
- References
- 248
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Update notices
- correction (2017-10-20)
- Open access
- hybrid
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.